Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AKR1C3-IN-8 (Compound 5) is an effective and selective AKR1C3 inhibitor (IC50=0.069 μM). AKR1C3-IN-8 has antitumor activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | AKR1C3-IN-8 (Compound 5) is an effective and selective AKR1C3 inhibitor (IC50=0.069 μM). AKR1C3-IN-8 has antitumor activity. |
In vitro | AKR1C3-IN-8 (Compound 5) exhibits antiproliferative effects, demonstrating an IC50 value of 52.06 ± 0.99 μM against the prostate cancer cell line 22rv1, and effectively inhibits PSA expression and testosterone production within the concentration range of 0-50 μM on 22RV1 cells [1]. |
Molecular Weight | 400.43 |
Formula | C23H20N4O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.